ID: ALA2402129

Max Phase: Preclinical

Molecular Formula: C34H37N5O5

Molecular Weight: 595.70

Molecule Type: Small molecule

Representations

Canonical SMILES:  C=CCn1c(=O)c(C2C(C(=O)OC(C)C)=C(N)N(NC(=O)c3ccncc3)C3=C2C(=O)CC(C)(C)C3)cc2cc(C)ccc21

Standard InChI:  InChI=1S/C34H37N5O5/c1-7-14-38-24-9-8-20(4)15-22(24)16-23(32(38)42)27-28-25(17-34(5,6)18-26(28)40)39(30(35)29(27)33(43)44-19(2)3)37-31(41)21-10-12-36-13-11-21/h7-13,15-16,19,27H,1,14,17-18,35H2,2-6H3,(H,37,41)

Standard InChI Key:  HVXSEOAIUTYTMZ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 595.70

Molecular Weight (Monoisotopic): 595.2795

AlogP: 4.40

#Rotatable Bonds: 7

Polar Surface Area: 136.62

Molecular Species: NEUTRAL

HBA: 9

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.07

CX Basic pKa: 3.17

CX LogP: 3.35

CX LogD: 3.35

Aromatic Rings: 3

Heavy Atoms: 44

QED Weighted: 0.30

Np Likeness Score: -0.95

References

1. Jardosh HH, Patel MP..  (2013)  Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.,  65  [PMID:23747804] [10.1016/j.ejmech.2013.05.003]

Source

Source(1):

• Scientific Literature